QNRX
Quoin Pharmaceuticals, Ltd.
NASDAQ · Healthcare · Biotechnology · US
$7.06
+0.71%8
Insider buys (3m)
0
Insider sells (3m)
$454.9K
Net value (3m)
+60.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Culverwell Anthony James · director | Purchase | 3,073 | $6.10 |
| Sep 1, 2026 | Carter Denise P. · director, officer: Chief Operating Officer | Purchase | 20,490 | $4.88 |
| Sep 1, 2026 | Carter Denise P. · director, officer: Chief Operating Officer | Purchase | 10,245 | $6.10 |
| Sep 1, 2026 | Myers Michael · director, officer: Chief Executive Officer | Purchase | 20,490 | $4.88 |
| Sep 1, 2026 | Myers Michael · director, officer: Chief Executive Officer | Purchase | 10,245 | $6.10 |
| Sep 1, 2026 | Lawlor Sally Bridget · officer: Chief Financial Officer | Purchase | 10,244 | $4.88 |
| Sep 1, 2026 | Lawlor Sally Bridget · officer: Chief Financial Officer | Purchase | 5,122 | $6.10 |
| Sep 1, 2026 | Culverwell Anthony James · director | Purchase | 6,146 | $4.88 |
| Aug 28, 2026 | Culverwell Anthony James · director | A-Award | 31,352 | $5.15 |
| Aug 28, 2026 | LANGER DENNIS · director | A-Award | 34,534 | $5.15 |
| Feb 6, 2026 | Leong Natalie Ee Mun · director | A-Award | 12,211 | $7.37 |
| Feb 6, 2026 | SEMBER MICHAEL T · director | A-Award | 8,141 | $7.37 |
| Feb 6, 2026 | LANGER DENNIS · director | A-Award | 21,709 | $7.37 |
| Feb 6, 2026 | Carter Denise P. · director, officer: Chief Operating Officer | A-Award | 318,750 | $7.37 |
| Feb 6, 2026 | Myers Michael · director, officer: Chief Executive Officer | A-Award | 318,750 | $7.37 |
| Feb 6, 2026 | Culverwell Anthony James · director | A-Award | 21,709 | $7.37 |
| Feb 6, 2026 | Cooper Joseph Patrick · director | A-Award | 8,141 | $7.37 |
| Feb 6, 2026 | Lawlor Sally Bridget · officer: Chief Financial Officer | A-Award | 85,250 | $7.37 |
| Dec 3, 2025 | Lawlor Sally Bridget · officer: Chief Financial Officer | A-Award | 10,330 | $19 |
| Oct 15, 2025 | LANGER DENNIS · director | Purchase | 15,152 | $8.49 |
| Aug 25, 2025 | LANGER DENNIS · director | A-Award | 13,682 | $9.07 |
| Aug 25, 2025 | Culverwell Anthony James · director | A-Award | 13,682 | $9.07 |
| Aug 25, 2025 | Leong Natalie Ee Mun · director | A-Award | 4,105 | $9.07 |
| Jun 13, 2025 | Myers Michael · director, officer: Chief Executive Officer | A-Award | 42,857 | $9.07 |
| Jun 13, 2025 | Carter Denise P. · director, officer: Chief Operating Officer | A-Award | 42,857 | $9.07 |
| Jun 3, 2025 | Culverwell Anthony James · director | A-Award | 7,760 | $9.07 |
| Jun 2, 2025 | Cooper Joseph Patrick · director | A-Award | 7,760 | $9.07 |
| Jun 2, 2025 | LANGER DENNIS · director | A-Award | 7,760 | $9.07 |
| Jun 2, 2025 | SEMBER MICHAEL T · director | A-Award | 7,760 | $9.07 |
| Jun 2, 2025 | Leong Natalie Ee Mun · director | A-Award | 7,760 | $9.07 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 15Reduced 8Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Dauntless Investment Group, LLC | Increased | 214,987 | Aug 13, 2026 |
| Ikarian Capital, LLC | Unchanged | 211,538 | Aug 14, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 211,538 | May 15, 2026 |
| Stonepine Capital Management, LLC | Increased | 199,486 | Aug 17, 2026 |
| DAUNTLESS INVESTMENT GROUP, LLC | New Position | 196,592 | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 112,323 | Aug 14, 2026 |
| SUMMITTX CAPITAL, L.P. | Increased | 100,300 | May 15, 2026 |
| SummitTX Capital, L.P. | Unchanged | 100,300 | Aug 14, 2026 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | New Position | 84,849 | May 15, 2026 |
| WOODLINE PARTNERS LP | Unchanged | 79,582 | May 15, 2026 |
| Woodline Partners LP | Reduced | 76,446 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 76,247 | May 15, 2026 |
| ABRDN PLC | Unchanged | 75,000 | Apr 29, 2026 |
| Aberdeen Group plc | Unchanged | 75,000 | Jul 31, 2026 |
| Soleus Capital Management, L.P. | Unchanged | 72,730 | Aug 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026